🇺🇸 MRK — Merck & Co., Inc.

Healthcare Compra
← Volver

Precio actual

150,33 USD

Máx. histórico

156,92

10 días

Split 1048:1000 del 03/06/2021

Caída desde máximo

-4,20%

Rango 52 semanas

77,58 – 156,92

Variación hoy

-1,32%

Cierre anterior

152,34

Rango de hoy

150,09 – 152,22

Volumen hoy

4.298.143

Información
Nombre completo
Merck & Co., Inc.
Divisa
USD
Mercado
NYSE
Sector
Healthcare
Industria
Drug Manufacturers - General
Empleados
73.000
PER ⓘ
120,26 (puede no estar actualizado)
Dividend yield
2,23% (puede no estar actualizado)
Precio objetivo analistas
149,50 USD (puede no estar actualizado)
Primera cotización
02/01/1962
Precio actualizado
hace 3 días
Sobre la empresa

Merck & Co., Inc. operates as a healthcare company worldwide. It offers human health pharmaceutical for various areas under the Keytruda, Keytruda Qlex, Welireg, Gardasil, ProQuad, M-M-R II, Varivax, Vaxneuvance, Capvaxive, RotaTeq, Pneumovax 23, Bridion, Prevymis, Dificid, Zerbaxa, Winrevair, Adempas/ Verquvo, Ohtuvayre, Lagevrio, Isentress/Isentress HD, Delstrigo, Pifeltro, Belsomra, Januvia, and Janumet brands. The company also provides veterinary pharmaceuticals, vaccines and health management solutions and services, such as livestock products under the Nuflor, Bovilis/Vista, Bovilis Cryptium, Banamine, Estrumate, Matrix, Resflor, Zuprevo, Revalor, Safe-Guard, M+Pac, Porcilis, Circumvent, Nobilis/Innovax, Paracox and Coccivac, Exzolt, Slice, Imvixa, Clynav, Aquavac/Norvax, Aquaflor, Flexolt brands; Allflex Livestock Intelligence solutions; and companion animal products under the Bravecto One-Month, Bravecto Injectable/Quantum, Bravecto TriUNO, Bravecto Plus, Sentinel Spectrum, Sentinel Flavor Tabs, Numelvi, Optimmune, Nobivac NXT, GilvetMab, Otomax, Mometamax, Mometamax Ultra, Posatex, Caninsulin/Vetsulin, Panacur, Safeguard, Regumate, Prestige, Scalibor/Exspot, Sure Petcare, and Home Again brands. It has development and commercialization agreement for three of Daiichi Sankyo's deruxtecan ADC candidates; AstraZeneca PLC to co-development and co-commercialize AstraZeneca's Lynparza products for multiple cancer types; licensed to develop, manufacture and commercialize LM-299, a novel investigational PD-1/VEGF bispecific antibody from LaNova; and collaboration agreement with Eisai Co., Ltd., Bayer AG, and Ridgeback Biotherapeutics LP, as well Moderna, Inc. Merck & Co., Inc. has strategic collaboration with Infinimmune, Inc. to discover and develop antibodies against multiple therapeutic targets. The company was founded in 1891 and is headquartered in Rahway, New Jersey.

Dividendos repartidos Total últimos 12 meses: 3,3600 USD · Yield: 2,24%
Fecha de pago Importe por participación
03/06/1985 0,0212 USD
28/02/1985 0,0212 USD
03/12/1984 0,0212 USD
31/08/1984 0,0199 USD
29/05/1984 0,0199 USD
01/03/1984 0,0199 USD
29/11/1983 0,0199 USD
29/08/1983 0,0186 USD
31/05/1983 0,0186 USD
28/02/1983 0,0186 USD
30/11/1982 0,0186 USD
30/08/1982 0,0186 USD
01/06/1982 0,0186 USD
01/03/1982 0,0186 USD
01/12/1981 0,0186 USD
Splits Registrados en el histórico de precios
Fecha Ratio
03/06/2021 1048:1000
17/02/1999 2:1
26/05/1992 3:1
26/05/1988 3:1
27/05/1986 2:1
01/06/1972 2:1
Rentabilidad mensual
Evolución
Histórico día a día
Fecha Apertura Máximo Mínimo Cierre Variación Volatilidad día Volumen
27/03/1992 23,46 23,48 23,10 23,20 -1,44% 1,61% 5.392.589
26/03/1992 23,87 23,89 23,50 23,54 -1,33% 1,67% 3.335.784
25/03/1992 23,93 24,07 23,82 23,86 +0,00% 1,08% 4.551.254
24/03/1992 23,54 23,89 23,42 23,86 +1,87% 2,03% 4.421.093
23/03/1992 23,40 23,48 23,22 23,42 +0,09% 1,10% 3.749.534
20/03/1992 23,56 23,60 23,24 23,40 -0,76% 1,52% 7.965.010
19/03/1992 23,66 23,68 23,50 23,58 +0,17% 0,76% 2.943.413
18/03/1992 23,80 23,89 23,54 23,54 -1,17% 1,50% 3.493.613
17/03/1992 23,48 23,84 23,48 23,82 +1,53% 1,52% 3.963.326
16/03/1992 23,48 23,50 23,22 23,46 -0,17% 1,19% 4.264.522
13/03/1992 23,66 23,70 23,22 23,50 +0,17% 2,02% 5.477.477
12/03/1992 23,87 23,91 23,34 23,46 -1,91% 2,41% 6.167.899
11/03/1992 24,09 24,15 23,86 23,91 -1,15% 1,24% 3.617.486
10/03/1992 24,07 24,33 24,07 24,19 +0,50% 1,07% 4.820.381
09/03/1992 23,89 24,17 23,89 24,07 +0,92% 1,16% 4.049.472
06/03/1992 24,07 24,21 23,78 23,86 -0,83% 1,82% 5.312.731
05/03/1992 24,01 24,31 24,01 24,05 +0,00% 1,24% 5.025.370
04/03/1992 24,47 24,49 23,84 24,05 -1,71% 2,68% 8.561.741
03/03/1992 24,95 24,97 24,47 24,47 -1,91% 1,99% 4.655.006
02/03/1992 25,05 25,13 24,87 24,95 -0,48% 1,03% 4.001.683
28/02/1992 25,21 25,25 24,85 25,07 -0,47% 1,58% 4.624.824
27/02/1992 25,31 25,45 25,09 25,19 -0,16% 1,41% 7.355.074
26/02/1992 24,63 25,33 24,49 25,23 +4,02% 3,39% 12.049.694
25/02/1992 23,99 24,25 23,95 24,25 +2,01% 1,24% 5.188.858
24/02/1992 23,22 23,86 23,22 23,78 +2,22% 2,74% 4.154.482
21/02/1992 23,46 23,62 23,02 23,26 -0,68% 2,54% 6.984.710
20/02/1992 23,16 23,58 23,16 23,42 +2,17% 1,80% 6.459.662
19/02/1992 23,20 23,22 22,82 22,92 -1,28% 1,71% 8.766.730
18/02/1992 23,74 23,86 23,22 23,22 -1,52% 2,68% 5.784.331
14/02/1992 23,89 23,91 23,56 23,58 -1,82% 1,50% 6.823.738